Garde Capital, Inc. Novo Nordisk A S Transaction History
Garde Capital, Inc.
- $1.87 Billion
- Q2 2025
A detailed history of Garde Capital, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Garde Capital, Inc. holds 1,185 shares of NVO stock, worth $58,989. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,185
Previous 850
39.41%
Holding current value
$58,989
Previous $59,000
37.29%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding NVO
# of Institutions
1,746Shares Held
338MCall Options Held
10.8MPut Options Held
15.9M-
Jennison Associates LLC18.9MShares$940 Million0.78% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$736 Million0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$617 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$613 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$591 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $112B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...